ACTRN12617000895381已完成未知
Implementation of the Goal-directed Medication review Electronic Decision Support System (G-MEDSS) into Home Medicines Review (HMR) to deprescribe medications in older adults - a cluster randomised controlled trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 201
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 65 Years 至 o limit（—）
- 性别
- All
入选标准
- •As this is a cluster randomised study, there are two tiers of recruitment: a) Australian registered accredited pharmacists who have conducted at least 24 HMRs in the last 12 months, and conduct 2-20 HMRs per month, will be eligible to participate in this study. b) eligibility for individual patients (with and without dementia) include: aged 65 years and older who can speak English, are eligible for a HMR (according to eligibility listed on http://6cpa.com.au/medication-management-programmes/home-medicines-review/), and are able to provide informed written consent (patient or carer).
排除标准
- •Pharmacists that are not accredited to conduct medication reviews, or conduct fewer than 24/year.
- •Patients <65 years old
研究者
相似试验
进行中（未招募）
1 期
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients.MedDRA version: 20.0 Level: LLT Classification code 10060614 Term: Hemophilia B (Factor IX) System Organ Class: 100000004850MedDRA version: 20.0 Level: LLT Classification code 10060613 Term: Hemophilia A (Factor VIII) System Organ Class: 100000004850HemophiliaEUCTR2018-003869-33-NLErasmus University Medical Center50
尚未招募
不适用
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patientsNL-OMON27791Erasmus Medical Center, Sophia Children's Hospital50
尚未招募
不适用
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients.hemophiliaNL-OMON55874Erasmus MC, Universitair Medisch Centrum Rotterdam50
招募中
不适用
Implementation of pharmacokinetic-guided dosing of DDAVP and VWF-containing concentrates in von Willebrand diseaseNL-OMON54546Erasmus MC, Universitair Medisch Centrum Rotterdam160
进行中（未招募）
1 期
Effects of pharmacokinetic models in dosing of DDAVP and/or von Willebrand factor-containing concentrates in patients with von Willebrand diseaseVon Willebrand diseaseMedDRA version: 20.0Level: LLTClassification code 10055168Term: Von Willebrand's factor deficiencySystem Organ Class: 100000004850EUCTR2018-001631-46-NLErasmus University Medical Center120